| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
15,875 |
12,359 |
$501K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
5,225 |
4,267 |
$132K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
651 |
528 |
$13K |
| 80305 |
|
1,710 |
1,457 |
$9K |
| 27096 |
|
207 |
127 |
$8K |
| 99215 |
Prolong outpt/office vis |
100 |
96 |
$7K |
| J3300 |
Injection, triamcinolone acetonide, preservative free, 1 mg |
34 |
30 |
$2K |
| 99205 |
Prolong outpt/office vis |
19 |
14 |
$2K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
909 |
588 |
$1K |
| 64493 |
|
16 |
12 |
$461.45 |
| 64494 |
|
16 |
12 |
$233.35 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
21 |
13 |
$148.51 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
18 |
12 |
$39.96 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
24 |
14 |
$5.28 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
47 |
26 |
$4.88 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
11,051 |
8,944 |
$0.37 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
11,729 |
9,745 |
$0.03 |
| G8730 |
Pain assessment documented as positive using a standardized tool and a follow-up plan is documented |
5,293 |
4,880 |
$0.00 |
| 99072 |
|
143 |
136 |
$0.00 |
| 0526F |
|
425 |
413 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
117 |
93 |
$0.00 |